Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin Faber

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Toxicology (Philadelphia, Pa.)|March 31, 2025
Paracetamol (acetaminophen) poisoning; consensus definitions of poisoning types and outcomes to be used in the clinical toxicology recommendations collaborative systematic reviewAngela L Chiew, David M Wood, Dazhe Cao, et al.
The Journal of Clinical Investigation|December 4, 2012
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signalingKatrin Faber, Lars Bullinger, Christine Ragu, et al.
The Journal of Experimental Medicine|March 28, 2012
Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33Ninel Azoitei, Christopher M Hoffmann, Jana M Ellegast, et al.
Blood|April 26, 2014
Requirement for CDK6 in MLL-rearranged acute myeloid leukemiaTheresa Placke, Katrin Faber, Atsushi Nonami, et al.
Nature Medicine|December 8, 2009
Comprehensive genomic access to vector integration in clinical gene therapyRichard Gabriel, Ralph Eckenberg, Anna Paruzynski, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Toxicology (Philadelphia, Pa.)|March 31, 2025
Paracetamol (acetaminophen) poisoning; consensus definitions of poisoning types and outcomes to be used in the clinical toxicology recommendations collaborative systematic reviewAngela L Chiew, David M Wood, Dazhe Cao, et al.
The Journal of Clinical Investigation|December 4, 2012
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signalingKatrin Faber, Lars Bullinger, Christine Ragu, et al.
The Journal of Experimental Medicine|March 28, 2012
Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33Ninel Azoitei, Christopher M Hoffmann, Jana M Ellegast, et al.
Blood|April 26, 2014
Requirement for CDK6 in MLL-rearranged acute myeloid leukemiaTheresa Placke, Katrin Faber, Atsushi Nonami, et al.
Nature Medicine|December 8, 2009
Comprehensive genomic access to vector integration in clinical gene therapyRichard Gabriel, Ralph Eckenberg, Anna Paruzynski, et al.
Pageof 2